Edges in Network
| Network | GSE5851_egf1520 - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | FZD3 |
| Upstream (Parents) |
|---|
| (<<) ARSA → FZD3 |
| (<<) ATF4 → FZD3 |
| (<<) BDH1 → FZD3 |
| (<<) CYP1A2 → FZD3 |
| (<<) DDX18 → FZD3 |
| (<<) DNM1L → FZD3 |
| (<<) GRHPR → FZD3 |
| (<<) PPP2R5C → FZD3 |
| (<<) PTK7 → FZD3 |
| (<<) RAB22A → FZD3 |
| (<<) RBKS → FZD3 |
| (<<) RCOR1 → FZD3 |
| (<<) SHC2 → FZD3 |
| (<<) SOCS2 → FZD3 |
| (<<) SULT1A1 → FZD3 |
| (<<) SULT1A2 → FZD3 |
| Downstream (Children) |
|---|
| FZD3 → CISH (>>) |
| FZD3 → COIL (>>) |
| FZD3 → PTPN12 (>>) |
| FZD3 → RGS20 (>>) |
| FZD3 → RRP15 (>>) |
| FZD3 → SEH1L (>>) |
| FZD3 → SLPI (>>) |
| FZD3 → SOX2 (>>) |
| FZD3 → TP53 (>>) |
| FZD3 → ZNF215 (>>) |
